[EN] NOVEL GLP-1 RECEPTOR MODULATORS<br/>[FR] NOUVEAUX MODULATEURS DU RÉCEPTEUR GLP-1
申请人:RECEPTOS INC
公开号:WO2016015014A1
公开(公告)日:2016-01-28
Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36), GLP-1(9-36), and oxyntomodulin, or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "〰" represents either or both the R and S form of the compound): where A, B, C, R1, R2, R3, R4, R5, n, p and q are as defined herein.
提供了一些化合物,这些化合物可以调节胰高血糖素样肽1(GLP-1)受体,以及它们的合成方法,以及它们的治疗和/或预防使用方法。这类化合物可以单独作为GLP-1受体的调节剂或增强剂,或者与肠促胰岛素肽(如GLP-1(7-36)、GLP-1(9-36)和oxyntomodulin)一起使用,或者与基于肽的治疗方法(如exenatide和liraglutide)一起使用,并且具有以下一般结构(其中"〰"代表化合物R和S形式的任一种或两种):其中A、B、C、R1、R2、R3、R4、R5、n、p和q如本文所述定义。